Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Vitamin boost and lifestyle coaching show promise for young adults in ghana

NCT ID NCT07031973

Disease control Sponsor: InnoNext Sarl Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether taking daily micronutrient supplements, with or without nutrition training and healthy lifestyle coaching, could improve the nutrition status and well-being of 150 young adults in Ghana. Participants were healthy university students aged 18-25. The main goal was to see if the supplements raised vitamin D levels in the blood over six months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

150 people

The number who actually took part.

Started

Feb 2025

Finished

Aug 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 25 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Apparently healthy students in their second and third years of study at University of Health and Allied Sciences, Fred N. Binka School of Public Health * Females and males aged 18 - 25 years * Agree to remain in the study area for the 26-week period of the follow-up * Gives written informed consent For female participants with childbearing potential: * No plan to get pregnant the next 7 months (Acceptance of the requirement to use a highly effective form of birth control (herein referred to as condom) effective from consenting until at least week 24 after the final intake of Investigational Product (Month 6 visit). Exclusion Criteria: * Individuals taking routine micronutrient supplements * History of food allergies * Sensitivity to micronutrient supplement consumption and to any compositions of the micronutrients * For females of child-bearing potential: pregnant as per serum pregnancy testing, or planning to become pregnant. * Taking medications that could interact with the micronutrient supplements. Key medications which deplete the absorption of micronutrients include acid-suppressing and antacids, antiepileptic drugs (anti-convulsants), antibiotics, hormone replacement therapy (estrogens), digoxin, anti-inflammatory/analgesics * Interested persons with severe anaemia (hemoglobin less than 7g/dl), as identified in the screening phase, will not be enrolled in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Micronutrient deficiencies are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

nutritional deficiency disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Micronutrient deficiencies

Contacts and locations

Locations

  • University of Health and Allied Sciences, Fred N. Binka School of Public Health

    Hohoe, Volta Region, 00233, Ghana

More trials for these conditions

Other studies related to the condition(s) this trial covers.